BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16054573)

  • 1. Antiemetic guidelines: are they being used?
    Kaiser R
    Lancet Oncol; 2005 Aug; 6(8):622-5. PubMed ID: 16054573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An antiemetic guideline for patients with malignancies in Japan].
    Takeuchi H; Saeki T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):976-979. PubMed ID: 20567095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
    Wickham R
    J Support Oncol; 2010; 8(2 Suppl 1):10-5. PubMed ID: 20629453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of adherence to guidelines for antiemetic medication enhances emetic control in patients with colorectal cancer receiving chemotherapy of moderate emetic risk.
    Fujii H; Iihara H; Ishihara M; Takahashi T; Yoshida K; Itoh Y
    Anticancer Res; 2013 Dec; 33(12):5549-56. PubMed ID: 24324096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
    Hesketh PJ
    Oncologist; 1999; 4(3):191-6. PubMed ID: 10394587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International patterns of practice in the management of radiation therapy-induced nausea and vomiting.
    Dennis K; Zhang L; Lutz S; van Baardwijk A; van der Linden Y; Holt T; Arnalot PF; Lagrange JL; Maranzano E; Liu R; Wong KH; Wong LC; Vassiliou V; Corn BW; De Angelis C; Holden L; Wong CS; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e49-60. PubMed ID: 22704982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic overuse in patients receiving chemotherapy.
    Das M
    Lancet Oncol; 2016 Oct; 17(10):e428. PubMed ID: 27667572
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiemetic guidelines: creating a more practical treatment approach.
    Koeller JM; Aapro MS; Gralla RJ; Grunberg SM; Hesketh PJ; Kris MG; Clark-Snow RA
    Support Care Cancer; 2002 Oct; 10(7):519-22. PubMed ID: 12324805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
    Chan A; Shih V; Chew L
    J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy.
    Drug Utilization Review Team in Oncology (DURTO)
    Support Care Cancer; 2003 Dec; 11(12):785-9. PubMed ID: 14579136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to and Implementation of ASCO Antiemetic Guidelines in Routine Practice in a Tertiary Cancer Center in India.
    Patil VM; Noronha V; Joshi A; Ramaswamy A; Gupta S; Sahu A; Doshi V; Gupta T; Rath S; Banavali S; Prabhash K
    J Oncol Pract; 2017 Jun; 13(6):e574-e581. PubMed ID: 28486012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The difficult trials.
    Herrstedt J
    Onkologie; 2009 Feb; 32(1-2):7-8. PubMed ID: 19209012
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiemetic research: future directions.
    Olver I; Molassiotis A; Aapro M; Herrstedt J; Grunberg S; Morrow G
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S49-55. PubMed ID: 21063733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A guideline for antimetics use for patients with malignancies].
    Horie Y; Boku N
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1163-8. PubMed ID: 22902437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.